Cibus (CBUS) Accounts Payables (2016 - 2026)
Cibus (CBUS) posted Accounts Payables of $8.1 million for Q4 2025, up 34.9% sequentially from $6.0 million in Q3 2025, and up 35.31% YoY from $6.0 million in Q4 2024.
Cibus (CBUS) Accounts Payables (2016 - 2026) Analysis & Trends
Cibus has reported Accounts Payables for 10 years, with the latest figure at $8.1 million in Q4 2025.
- Quarterly Accounts Payables rose 35.31% year-over-year to $8.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.1 million (up 35.31% YoY) and the FY2025 annual result came in at $8.1 million, up 35.31% from the prior year.
- Accounts Payables climbed to $8.1 million in Q4 2025 per CBUS's latest filing, from $6.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $8.1 million in Q4 2025 and troughed at $327000.0 in Q1 2023.
- A 5-year average of $3.9 million and a median of $4.9 million in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2024: Accounts Payables slumped 76.23% in 2022, then jumped 1940.37% in 2024.
- Over 5 years, Accounts Payables stood at $1.3 million in 2021, then tumbled by 73.02% to $340000.0 in 2022, then soared by 1702.06% to $6.1 million in 2023, then fell by 2.66% to $6.0 million in 2024, then surged by 35.31% to $8.1 million in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $8.1 million, $6.0 million, and $5.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.61 Mn |
| Dec 31, 2025 | 8.07 Mn |
| Sep 30, 2025 | 5.98 Mn |
| Jun 30, 2025 | 5.93 Mn |
| Mar 31, 2025 | 6.78 Mn |
| Dec 31, 2024 | 5.96 Mn |
| Sep 30, 2024 | 7.02 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 6.67 Mn |
| Dec 31, 2023 | 6.13 Mn |
| Sep 30, 2023 | 6.28 Mn |
| Jun 30, 2023 | 3.96 Mn |
| Mar 31, 2023 | 327,000.00 |
| Dec 31, 2022 | 340,000.00 |
| Sep 30, 2022 | 435,000.00 |
| Jun 30, 2022 | 519,000.00 |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 2.18 Mn |